Leadership
Dr. Marvin J. Fritzler
Dr. Marvin J. Fritzler, the founder of MitogenDx, has served as its Director for over 40 years. In addition to Mitogen, Dr. Fritzler has also served as a Professor at the University of Calgary, Cumming School of Medicine. Receiving his PhD in Cell Biology at the University of Calgary, Dr. Fritzler continued with postdoctoral research in Autoimmunity at the Scripps Clinic and Research Institute in La Jolla, CA and at the University of Colorado. His areas of expertise include autoimmune diseases, cell and molecular biology of autoantigens, and laboratory diagnostics. Under Dr. Fritzler’s leadership and driven by his passion for precision health, MitogenDx has gained recognition and provides diagnostic services on a local, national, and international scale.
Education
- Post-Doctoral: Autoimmunity (Scripps Clinic and Research Institute, University of Colorado)
- PhD: Cell Biology (University of Calgary)
- MD: Medicine (University of Calgary)
- BSc: Zoology/Biology (University of Alberta)
Areas of Expertise
- Autoimmune Diseases
- Environmental Medicine
- Cell and Molecular Biology of Autoantigens
- Precision Medicine
- Laboratory Diagnostics
- Strategy & Policy: Science, Research, Technology, Innovation
Key Member of Team Research
- Canadian Scleroderma Research Group
- Canadian Inflammatory Myopathy Study (CIMS)
- UCAN-CANDU-CANCure: Canada–Netherlands Study of Juvenile Arthritis
- Tri-Nation (Canada, USA, Australia) Scleroderma Research Group
- CAN-RIO: Canadian Centres Studying Checkpoint Inhibitor Adverse Effects
- LEAPPS: Longitudinal Examination of ANA Prevalence, Predictors and Performance in SLE